2022
DOI: 10.5603/hcp.a2022.0001
|View full text |Cite
|
Sign up to set email alerts
|

Polyserositis (pericarditis and bilateral pleural effusion) after COVID-19 mRNA vaccine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…However, unlike our case, pleural effusion, in that case, was part of a multisystemic inflammatory syndrome. Recently, Two cases were reported describing polyserositis involving pericardial and pleural effusion [11,14]. A hemorrhagic variant of pleural effusion was also reported [4].…”
Section: Discussionmentioning
confidence: 98%
“…However, unlike our case, pleural effusion, in that case, was part of a multisystemic inflammatory syndrome. Recently, Two cases were reported describing polyserositis involving pericardial and pleural effusion [11,14]. A hemorrhagic variant of pleural effusion was also reported [4].…”
Section: Discussionmentioning
confidence: 98%
“…Myocarditis and pericarditis with or without coexisting pleural effusions are some of the rarer adverse events encountered in individuals receiving the BNT162b2 vaccination, and if encountered, are usually observed in men under 40 years old in the first week following injection of the second primary series dose or first booster dose, with most booster doses likely administered at least 5 months after completing the primary vaccination [ 4 , 5 , 6 , 14 , 15 , 16 , 17 ]. Additionally, a rare case of latent herpes zoster reactivation has been published, linked to the administration of the mRNA COVID-19 vaccine, where in rare cases the presence of VZV can be associated with pleural effusions [ 18 , 19 ].…”
Section: Discussionmentioning
confidence: 99%